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Abstract
Exploring optimal cure of Methicillin Resistant Staphylococcus aureus 
(MRSA), has been consistently challenged by clinical physicians and 
microbiologist. The fatal bacterial infection, Methicillin Resistant Sta-
phylococcus aureus (MRSA), shows unique resistance; when selected 
drugs are tested on human patients. If holistic approach is overlooked, 
less possibilities are left for medication to curtail this lethal toxicity. 
If single range of drug treatment is exercised only, the associated 
complications and consequences of infections may proliferate beyond 
threshold levels. The research article is an outcome from primary mi-
crobial data collection (from urine and blood) in hospital. The focus 
of experiment is to scrutinize the highest risk vulnerable hospital area 
including sampled fluid. The preventive and therapeutic measures are 
discussed along with multiple substitutes of medication with prudent 
selection to achieve targeted and optimum outcome.
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Introduction
Microbiologists are witnessing an exponential growth in infectious 
human diseases through Staphylococcus aureus (S. aureus), which is 
exactly known as Methicillin Sensitive Staphylococcus aureus (MSSA) 
[1]. In this case, bacterial skin infections are due to the strains (i.e. in-
vasive) of Methicillin Resistant Staphylococcus aureus (MRSA) [2]. The 
microbe has latency to severely resist antibiotics as observed in the last 
decade. The human race is facing significant morbidity caused by the-
se lethal infections. These are also cause of constant worry (including 
both economic and financial) on health care system. The focus of this 
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empirical study is to propose an ingenious approach 
to find out optimal solution by applying preventive 
measures to control epidemic. It also focuses on 
using localized treatment and alternative medicines 
to cure and treat the menace of infections produced 
by MRSA in human [3].
Perspectives and Approaches
People not involved in health care settings are often 
less aware of this silent and lethal epidemic. This 
lack of awareness lies in significance of risk, perils 
of hospital acquired MRSA infection, and potential 
threat to overall health care system. A significant 
public behavioural change is needed in order to 
control this global menace as well as a well-infor-
med public.
Controlling MRSA is a clinical challenge faced 
by clinicians across the world [4]. The objective of 
the study is to figure out optimal and convenient 
methods to treat infections caused by MRSA in hu-
man. The focus of research is to consider alternative 
medicine including natural, herbal, ayurvedic, ho-
meopathic, and Chinese medicine. Modern thera-
peutic methods like radio waves, laser therapy, and 
nuclear and radioactive radiations are essential as 
well as effective. These not only boost natural phy-
siological immune system but also efficiently reduce 
the infectious effects and therapeutic side effects 
on human body [5].
Location
S. aureus is found abundantly in damp health-
care environment. People who are weaker, older 
and sicker have weaker immune system and may 
get infected easily. Many individuals either living 
or functioning closely together provide congenial 
setting for transmission of infectious diseases. It is 
also reported that people may carry this infection 
without having any visible indications. 
It is a highly contagious bacterial species found 
throughout the ecosystem [5, 6]. The microorga-
nism invades the skin and enters deeper tissues. As 
in septicaemia, it multiplies to cause a localized or 
systemic response. The patient gets infected with 
the growth of its population. 
Origination
The choice of antibiotics as efficient and effecti-
ve treatment is reduced after the maturity of in-
fection. Such methods are expensive and possibly 
show harmful side effects to the patient. Recent 
evidence supports that domestic pets like cat, dog 
and hen can transmit MRSA to their owners [7]. 
Production of β – lactamase enzyme in the affec-
ted area is the main cause of microbial resistan-
ce. Some strain of MRSA are labelled as epidemic 
strains (EMRSA) [8]. Seventeen variants of EMRSA 
strain have been explored in the globe [9]. Re-
cently, common strain variant to affect hospitals is 
EMRSA sixteen [10, 11]. 
Material and Methods
Holy Family Hospital is an eight hundred bed tertiary 
teaching hospital located in the city Rawalpindi, Pa-
kistan. An empirical study on MRSA was conduc-
ted here from November to December 2014. The 
patients were clinically spotted. Later on, the data 
was gathered using the information and support 
system from the targeted hospital. For this purpose, 
collection of samples was gathered in containers 
which were pre-sterile using aseptic technique by 
healthcare team and transported to the laboratory 
by brain – heart infusion broth (BHIB) medium in 
controlled environment without delay for immedia-
te processing.
Mannitol Salt agar and Chocolate agar were used 
for the identification and isolation of S. aureus [12]. 
The collected samples were inoculated onto Cho-
colate agar as well as on Mannitol Salt agar [13]. 
Two tests were used to identify the type of bacteria 
namely; coagulase and catalase [14]. The identifi-
cation of S. aureus suspicious grown colonies was 
based on gram staining and standard biochemical 
reactions, including catalase and coagulase [15].
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The Chocolate agar plates were incubated in a 
ten percent (10%) carbon dioxide incubator at 37oC 
for 24 hours. The Mannitol Salt agar (MSA) plates 
were incubated for 18-72 hours at 30-35oC [16]. 
Standard microbiological techniques are applied to 
identify particular bacterial characteristics [17].
Methicillin Resistant Staphylococcus aureus was 
identified by using Vancomycin (30µg) and Oxa-
cillin (1µg) disks as recommended by Clinical and 
Laboratory Standard Institute (CLSI) [18]. Inducible 
resistance was identified in S. aureus by disk ap-
proximation test [19]. The data was documented 
and analysed for the completion of this study. A 
reference strain S. aureus ATCC 25923 was used 
for the standardization of antibiotic susceptibility 
testing [20, 21].
Results
A total of 920 samples were processed from in-pa-
tients; which comprises 503 samples of Blood and 
remaining were Urine (Table 1). The sample contai-
ned 37% MRSA-identified in ICU and Special Care 
Baby Unit (both Blood and Urine processed sam-
ples) which depicted as clinically high risk. Whereas 
Vascular Unit contains 30% MRSA Positive samples 
(both Blood and Urine processed samples) which 
depicted as moderate risk. General Medicine Unit 
contains 25% MRSA Positive samples (both Blood 
and Urine processed samples) which depicted as 
low risk. Psychogeriatric Unit contains 15% MRSA 
identified samples (both Blood and Urine processed 
samples) which depicted as clinically minimal risk. 
Sampled data tabulated in Table 1 is graphically de-
picted in Figure 1 and Figure 2. To conclude, overall 
the study showed high prevalence of MRSA (32%) 
Table 1. Fluid Samples Processed from Hospitalized In-Patients.
Risk in 
Percentage
Unit or Department
Blood (Samples Processed) Urine (Samples Processed) Total Samples 
with MRSA 
Positive 
Collected 
Samples
Samples with 
MRSA Positive
Collected 
Samples
Samples with 
MRSA Positive
High 
(≥ 31%)
Special Care Baby Unit 37 14 28 10 37%
Intensive Care Unit 172 68 137 46 37%
Burns Unit 22 8 20 7 36%
Transplant Unit 10 3 10 4 35%
Cardiothoracic 17 9 25 5 33%
Orthopedic 14 7 13 2 33%
General Surgery 35 11 24 8 32%
Urology 40 9 45 17 31%
Moderate 
(≥26%)
Vascular 18 7 15 3 30%
Neonatal 9 3 8 2 29%
Obstetrics 8 2 9 3 29%
Trauma 17 5 8 2 28%
Gynecology 10 3 8 2 28%
Dermatology 34 8 25 8 27%
Low 
(≥21%)
General Medicine 7 2 5 1 25%
Children (not neonates) 16 3 6 2 23%
Minimal 
(<21%)
Psychiatric 18 5 10 0 18%
Psychogeriatric 19 3 21 3 15%
Grand Total 503 170 417 125 32%
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Figure 1: Processed Samples of Urine.
Figure 2: Processed Samples of Blood.
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among in-door hospitalized human patients in their 
processed blood and urine samples. 
Discussion
Pre-emptive Measures (Economical and 
Convenient)
Following measures are essentially taken to prevent 
early spread of infectious diseases. These measures 
must be taken by each and every individual especia-
lly persons dealing with them in healthcare systems.
Appropriate hand washing (including areas bet-
ween fingers and nails) is generally accepted to be 
the first necessary action used for decreasing the 
infection risk. Alternatively, alcohol-hand-rub can 
be applied for decontamination. Maintain cleanli-
ness of hands when contact with patients, replacing 
bed linen as well as bedding, careful handling of 
anything contaminated with body fluids, removing 
protective clothing and gloves, prior to aseptic te-
chnique, handling invasive devices and also before 
handling food. MRSA is both airborne and water-
borne disease so maintain cleanliness of general 
environment including atmosphere. Also maintain 
an appropriate ratio of staff to patient. Keep nails 
clean, short as well as polish free, avoid wearing 
finger-ring and wristwatch, are considered among 
the best preventive measure [5, 17].
Therapeutic Measures
The use of oral antibiotics and topical Mupirocin 
directed towards common skin flora is the first line 
of treatment for mild skin infections [22]. Topical 
antibiotics are useful for less severe infectious ca-
ses. MRSA strains are highly resistant to various an-
tibiotics including Cephalosporins, Macrolides and 
Quinolones.
The use of systemic antibiotic should be reser-
ved for mild to moderate or severe infections that 
cover a large surface area. The use of an antimicro-
bial agent is highly recommended for the purpose 
of treatment. Antibiotics like Ciprofloxacin, Sulfa-
methoxazole, Trimethoprim, Linezolid, Rifampin or 
Vancomycin are right options for treatment [23]. It is 
noticed that most of the infections with appropriate 
treatment resolved within ten days. If symptoms do 
not resolve then the right mix of antibiotics and me-
dicine may be recommended. It can simultaneously 
defend and destroy the bacterial invasion in the 
body and boost the self-immune system with least 
side effects.
Alternative Remedies
Herbal drug treatment may be adapted such as 
turmeric (dried rhizome of Curcuma longa belonging 
to family Zingiberaceae) [24], olive leaves extract, 
and essential oils such as tea tree oil or lavender 
oil, black drawing salve, bentonite clay ichthammol 
ointment may be applied. Specialists also suggest 
washing the infected area with hydrogen peroxide 
before applying the bentonite clay [25].
Selective range of electromagnetic waves and 
radio-nuclear therapy may be adopted as localized 
modern clinical treatment. MRSA was detected sen-
sitive towards both solar (Ultraviolet A & B) as well 
as germicidal (Ultraviolet C) ultraviolet radiation. Ul-
traviolet-C radiation is substantially more lethal. The 
calculated exposure of both solar and germicidal 
ultraviolet radiation increases the concentration of 
Sodium Chloride (NaCl) medium where cells exhibit 
increase in sensitivity.
The most common homeopathic treatment for 
MRSA may include Pulsatilla and Aconitum (genera 
in the family of Ranunculaceae) and also belladonna 
(species in the family of Solanaceae) [26]. Pulsatilla 
is a homeopathic remedy especially recommended 
in women and children. Aconitum is proven to be 
helpful in all kinds of infection including MRSA. In 
homeopathic doses, belladonna remedy (extremely 
small doses) is also used to cure the red skin, often 
associated with the infections [27].
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Conclusion
The study showed high prevalence of MRSA (37%) 
among sampled in-door hospitalized human pa-
tients’ fluid; who belong to Intensive Care Unit 
(ICU) and Special Care Baby Unit. To minimize the 
extent of infection, healthcare staff should make 
sure that they wash their hands with sterile liquid 
thoroughly between patient’s clinical examinations. 
Hand washing is advised for attendants and visi-
tors too. Healthcare associated infection should be 
highlighted prominently on the media at national 
and international level for public awareness. Howe-
ver, the affected patients can socialize as usual but 
proper decontamination of hands and use of face 
mask need to be incorporated. An integrated drug 
therapy approach should be adopted to deplete 
the cause and effect, and simultaneously boost the 
natural physiological immune system for optimum 
outcome.
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